Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Gene Ontology annotation of human sequence-specific DNA binding transcription factors (DbTFs) based on the TFClass database
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Crystal structure of a transcriptionally active Smad4 fragment.
-
The SMAD4 activation fragment crystallizes as a trimer with sulfate ions proposed to mimic phosphorylated R-SMAD contacts.
"The structure of the S4AF trimer reveals novel features important for Smad4 function."
-
The SMAD4 activation fragment crystallizes as a trimer with sulfate ions proposed to mimic phosphorylated R-SMAD contacts.
"A tandem sulfate-ion-binding site was identified within the subunit interface, which may interact with the phosphorylated C-terminal sequence of pathway-restricted SMAD proteins."
Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter.
Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone.
Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling.
Structural basis of Smad1 activation by receptor kinase phosphorylation.
Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Stoichiometry of active smad-transcription factor complexes on DNA.
Cellular response to hypoxia involves signaling via Smad proteins.
-
Hypoxia induces SMAD2/3 activation in endothelial cells; the accessible abstract does not resolve SMAD4-specific effects.
"Exposure of HUVECs to hypoxia resulted in phosphorylation and nuclear transportation of Smad2 and Smad3 proteins as well as stimulation of transcriptional activities of Smad3 and the transcription factor hypoxia-inducible factor-1alpha and culminated in up-regulation of TGF-beta2 gene expression."
Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling.
DACH1 inhibits transforming growth factor-beta signaling through binding Smad4.
A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes.
-
EID2 interacts with SMAD proteins and represses signaling by disrupting SMAD3-SMAD4 complex formation.
"EID-2 interacts constitutively with Smad proteins, and most strongly with Smad3."
Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells.
Signal transduction of bone morphogenetic protein receptors.
Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.
Nodal and ALK7 inhibit proliferation and induce apoptosis in human trophoblast cells.
Functional proteomics mapping of a human signaling pathway.
Structural basis of heteromeric smad protein assembly in TGF-beta signaling.
-
Structures establish heterotrimers containing two phosphorylated R-SMAD subunits and one SMAD4.
"Both complexes are heterotrimers, comprising two phosphorylated R-Smad subunits and one Smad4 subunit, a finding that was corroborated by isothermal titration calorimetry and mutational studies."
Nuclear targeting of transforming growth factor-beta-activated Smad complexes.
Tsc-22 enhances TGF-beta signaling by associating with Smad4 and induces erythroid cell differentiation.
Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway.
Towards a proteome-scale map of the human protein-protein interaction network.
Smad transcription factors.
The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity.
-
hZimp10 interacts with SMAD3/4 and enhances SMAD-dependent transcription.
"A protein-protein interaction between Smad3 and Smad4 with hZimp10 was identified in glutathione S-transferase-pulldown and co-immunoprecipitation assays."
Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation.
Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS.
Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1.
3-Phosphoinositide-dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins.
Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling.
TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal.
Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1.
HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.
Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5.
FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.
A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
-
BMP9 induces SMAD2-dependent inflammatory transcription and SMAD4-dependent target-gene responses in human endothelial cells.
"BMP9-mediated mRNA transcription, including induction of BMPR-II and endoglin, is Smad4-dependent."
An atlas of combinatorial transcriptional regulation in mouse and man.
TIF1gamma controls erythroid cell fate by regulating transcription elongation.
Homeodomain protein DLX4 counteracts key transcriptional control mechanisms of the TGF-β cytostatic program and blocks the antiproliferative effect of TGF-β.
Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells.
HEB and E2A function as SMAD/FOXH1 cofactors.
-
SMAD2/3/4 and FOXH1 occupy regulatory DNA in human embryonic stem cells and derived endoderm.
"We identified a new motif, termed SMAD complex-associated (SCA), that is bound by SMAD2/3/4 and FOXH1 in human embryonic stem cells (hESCs) and derived endoderm."
Toward an understanding of the protein interaction network of the human liver.
Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3.
Germline mutations in SMAD4 disrupt bone morphogenetic protein signaling.
miR-125 potentiates early neural specification of human embryonic stem cells.
-
miR125-mediated regulation of SMAD4 influences early neural specification of human embryonic stem cells.
"This was associated with the regulation by miR-125 of SMAD4, a key regulator of pluripotent stem cell lineage commitment."
Intercellular variation in signaling through the TGF-β pathway and its relation to cell density and cell cycle phase.
Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway.
-
miR199a targets SMAD4 and weakens TGF-beta-dependent growth arrest and apoptosis in gastric cancer cells.
"Overexpression of miR-199a significantly inhibited the ability of TGF-β to induce gastric cancer cell growth arrest and apoptosis in vitro, and promoted anchorage-independent growth in soft agar, suggesting that miR-199a plays an oncogenic role in human gastric tumourigenesis."
COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacification by targeting SMAD4.
Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma.
microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer.
-
SMAD4 overexpression reduces TCF reporter activity in the tested prostate cancer cells.
"Tcf transcriptional activity was decreased to 70% in Dkk-3- or/and SMAD4-transfected PC-3 cells compared with control, indicating that Dkk-3 and SMAD4 inhibits the β-catenin-depending pathway in PC cells (Figure 7D).Effect of miR-183 on Wnt-β-catenin pathwayAs TOPflash luciferase activity was significantly decreased with Dkk-3 and SMAD4 overexpression, we also performed the same assay using miR-183 inhibitor."
The protein interaction landscape of the human CMGC kinase group.
Charting the molecular links between driver and susceptibility genes in colorectal cancer.
Sustained induction of collagen synthesis by TGF-β requires regulated intramembrane proteolysis of CREB3L1.
A proteome-scale map of the human interactome network.
A massively parallel pipeline to clone DNA variants and examine molecular phenotypes of human disease mutations.
Pokemon (FBI-1) interacts with Smad4 to repress TGF-β-induced transcriptional responses.
Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.
Widespread macromolecular interaction perturbations in human genetic disorders.
MicroRNA-483-3p Inhibits Extracellular Matrix Production by Targeting Smad4 in Human Trabecular Meshwork Cells.
The formation and function of the cardiac conduction system.
Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome.
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy.
Pooled-matrix protein interaction screens using Barcode Fusion Genetics.
An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders.
LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells.
miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells.
-
SMAD4 knockdown partly reverses TGF-beta-induced epithelial transition, migration and invasion in EC1 cells.
"knocked down SMAD4 could partially reverse TGF-β-induced migration, invasion, and EMT progression in the ESCC cell line EC-1."
Maximizing binary interactome mapping with a minimal number of assays.
Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.
Structural basis for distinct roles of SMAD2 and SMAD3 in FOXH1 pioneer-directed TGF-β signaling.
-
Properly folded human SMAD2 has E3-regulated intrinsic DNA-binding activity; SMAD4 also binds regulatory DNA directly.
"Thus activated, SMAD2 and SMAD3 form complexes with SMAD4, accumulate in the nucleus, and recruit coactivators and repressors to regulate the expression of target genes."
-
Properly folded human SMAD2 has E3-regulated intrinsic DNA-binding activity; SMAD4 also binds regulatory DNA directly.
"the full-length SMAD4 protein bound the Gsc1 probe at values between 0.15 and 0.30 µM (Fig."
-
Properly folded human SMAD2 has E3-regulated intrinsic DNA-binding activity; SMAD4 also binds regulatory DNA directly.
"The SMAD2 MH1 domain and full-length proteins also bound to different 5GC probes (Gsc1 and Gsc2 probes) from the Gsc promoter in the 0.6–1.2 µM concentration range"
-
Properly folded human SMAD2 has E3-regulated intrinsic DNA-binding activity; SMAD4 also binds regulatory DNA directly.
"TGF-β, Nodal, and Activin receptors phosphorylate SMAD2 and SMAD3."
A reference map of the human binary protein interactome.
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
The Interplay Between TGF-β Signaling and Cell Metabolism.
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.
Gain-of-function variants in SMAD4 compromise respiratory epithelial function.
Multimodal cell maps as a foundation for structural and functional genomics.
A human Mad protein acting as a BMP-regulated transcriptional activator.
Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.
Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4.
Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium.
-
SMAD6 interacts with assayed human SMAD2 and SMAD4 proteins.
"Smad6 interacted with all species tested (Smad1, Smad2, and Smad4), whereas Smad7 interacted only with Smad6 (Fig."
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
-
Receptor activation induces SMAD2/3/4 association, nuclear accumulation and synergistic transcription.
"Smads 2, 3 and 4 accumulated in the nucleus upon TGF-beta1 treatment in Mv1Lu cells, and showed a synergistic effect in a transcriptional reporter assay using the TGF-beta-inducible plasminogen activator inhibitor-1 promoter."
-
Receptor activation induces SMAD2/3/4 association, nuclear accumulation and synergistic transcription.
"Smads 2 and 3 interacted with Smad4 after TbetaR activation in transfected COS cells."
Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor.
Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator.
-
SMAD4 transcriptional activation requires hetero-oligomerization and is enhanced by associated transactivators.
"Hetero-oligomerization of Smad4 with the pathway-restricted SMAD proteins is essential for Smad4-mediated transcription."
Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
POU5F1 (OCT4), SOX2, NANOG, ZSCAN10, PRDM14, SMAD2, FOXP1-ES bind the POU5F1 (OCT4) promoter
Phospho R-SMAD(SMAD2/3):CO-SMAD(SMAD4):FOXO3 binds FoxO3a-binding elements
Phosphorylated SMAD2 and SMAD3 form a complex with SMAD4
SKI/SKIL binds SMAD complex, suppressing TGF-beta signaling
The SMAD2/3:SMAD4 complex transfers to the nucleus
Ubiquitin-dependent degradation of the SMAD complex terminates TGF-beta signaling
Phospho-R-Smad1/5/8 forms a complex with Co-Smad
SKI complexes with the Smad complex, suppressing BMP2 signalling
Ubiquitin-dependent degradation of the Smad complex terminates BMP2 signalling
The phospho-R-Smad1/5/8:Co-Smad transfers to the nucleus
WWTR1 binds SMAD2/3:SMAD4 heterotrimer
PPM1A dephosphorylates nuclear SMAD2/3
WWTR1:SMAD translocates to the nucleus
SMAD2/3:SMAD4 heterotrimer forms a complex with RBL1, E2F4/5 and DP1/2
Phosphorylation of SMAD2 and SMAD3 linker regions by CDK8 or CDK9
NEDD4L binds phosphorylated linker region of SMAD2/3
NEDD4L ubiquitinates SMAD2/3
Degradation of SMAD2/3:SMAD4 complex
SMURF2 binds SMAD3 phosphorylated in the linker region
SMURF2 monoubiquitinates SMAD3
TGIF recruits HDAC1 to SMAD2/3:SMAD4 heterotrimer
MEN1 binds SMAD2/3:SMAD4 heterotrimer
SMAD2/3:SMAD4 heterotrimer binds SP1
PARP1 ADP-ribosylates SMAD3 and SMAD4
PARP1 binds SMAD2/3:SMAD4 heterotrimer
PPM1A protein phosphatase binds phosphorylated SMAD2/3
SMAD4 MH2 Domain Mutants do not bind phosphorylated SMAD2 and SMAD3
Phosphorylated SMAD2/3 MH2 Domain Mutants do not bind SMAD4
POU5F1 (OCT4), SOX2, NANOG, KLF4, PBX1, SMAD2 bind the NANOG promoter
USP9X (FAM) deubiquitinates SMAD4
TRIM33 monoubiquitinates SMAD4
Ubiquitinated SMAD4 translocates from the nucleus to the cytosol
USP9X (FAM) binds to ubiquitinated SMAD4
TRIM33 (Ectodermin) binds SMAD heterotrimer in the nucleus
RUNX2 binds SMAD1 in the nucleus
RUNX2 and SMAD1 complex binds the SMAD6 gene promoter
RUNX3 binds SMAD3 and SMAD4
The complex of RUNX3, SMAD3 and SMAD4 binds the CDKN1A gene promoter
RUNX3 binds the BCL2L11 (BIM) gene
FOXO1,FOXO3,FOXO4 bind p-2S-SMAD2/3:SMAD4
FOXO:SMAD complex binds CDKN1A gene promoter
FOXG1 binds FOXO:SMAD complexes
p-2S-SMAD3:p-2S-SMAD3:SMAD4 forms a complex with SP1 and EP300 at the COL1A2 gene promoter
YBX1 binds COL1A2 gene promoter
WWTR1:p-2S-SMAD2,3:SMAD4 binds SERPINE1 gene promoter
WWTR1:p-2S-SMAD2,3:SMAD4 binds SMAD7 gene promoter
p-2S-SMAD2,3:SMAD4:SP1 binds CDKN2B gene promoter
p-2S-SMAD2,3:SMAD4:RBL1:E2F4,5:DP1,2 binds MYC gene promoter
p-2S-SMAD2,3:SMAD4 binds JUNB gene promoter
SARS-CoV-1 N binds SMAD3 and EP300 at the SERPINE1 gene promoter
EOMES, SMAD2,3, and GATA6 bind the CXCR4 gene
SMAD2,3 and GATA6-AS1 lncRNA bind the GATA6 gene
Rnf111 binds SKI/SKIL in complex with SMAD2/3:SMAD4 upon TGF-beta stimulation
Ubiquitination of SKI/SKIL by Rnf111
FOXO1,FOXO3 and SMAD3 bind Trim63 gene promoter
Follicle-stimulating hormone synthesis and fertility depend on SMAD4 and FOXL2.
-
Gonadotrope SMAD4 supports FSH synthesis and fertility, linking activin transcription to follicular development.
"SMAD4, is absolutely required for normal FSH synthesis in both male and female mice."
Non-virus-mediated transfer of siRNAs against Runx2 and Smad4 inhibit heterotopic ossification in rats.
-
Smad4-directed RNA interference inhibits ectopic ossification in a rat model.
"the Runx2- and Smad4-specific siRNAs inhibited the expression of Runx2 and Smad4 at the level of messenger RNA and protein."
Endoglin is required for myogenic differentiation potential of neural crest stem cells.
-
Conditional Smad4 loss in neural crest is associated with outflow-tract defects in the endoglin study.
"Wnt1cre;Sm4c/n;TgEng loxP embryos demonstrated characteristic defects in the outflow tract, persistent truncus arteriosus, in which there was a loss of septation of the aorta and pulmonary trunk which form the outflow tract ( Fig."
Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. [corrected].
-
SMAD4 cooperates with GATA4 on Id2 transcription and is required for endothelial valve-forming activity.
"Endothelial-specific knockout of Smad4 caused an absence of valve-forming activity: Smad4-deficient endocardium was associated with acellular endocardial cushions, absent epithelial-to-mesenchymal transformation, reduced endocardial proliferation, and loss of Id2 expression in valve-forming regions."
-
SMAD4 cooperates with GATA4 on Id2 transcription and is required for endothelial valve-forming activity.
"Gata4 and Smad4 cooperatively activated the Id2 promoter, that human GATA4 mutations abrogated this activity, and that Id2 deficiency in mice could cause atrioventricular septal defects."
Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
-
Cardiomyocyte Smad4 loss causes hypertrophy, reduced contractility and increased MEK-ERK activation in mice.
"the deletion of Smad4 in cardiomyocytes resulted in cardiac hypertrophy characterized by an increase in the size of cardiac myocytes, age-associated fibrosis, and reexpression of certain fetal genes."
-
Cardiomyocyte Smad4 loss causes hypertrophy, reduced contractility and increased MEK-ERK activation in mice.
"phosphorylated extracellular signal-regulated kinase (ERK) 1/2 and mitogen-activated protein kinase-ERK (MEK) 1 were increased in the Smad4 mutants, suggesting that an upregulation of MEK1-ERK1/2 signaling as a consequence of deletion of Smad4 underlies the impaired cardiac function."
Interaction of Smads with collagen types I, III, and V.
-
Collagens bind SMAD4 protein and its MH2 domain in vitro; physiological intracellular contact remains unresolved.
"Each collagen also bound to the MH2 domains of Smads 4 and 7 and, to a lesser extent, full-length Smads 1, 2, 3, and 4."
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression.
-
Liver SMAD4 promotes hepcidin expression and iron homeostasis, including hepcidin responses to IL6.
"a Cre-loxP-mediated liver-specific disruption of SMAD4 results in markedly decreased hepcidin expression and accumulation of iron in many organs, which is most pronounced in liver, kidney, and pancreas."
-
Liver SMAD4 promotes hepcidin expression and iron homeostasis, including hepcidin responses to IL6.
"transcriptional activation of hepcidin is abrogated in SMAD4-deficient hepatocytes in response to iron overload, TGF-beta, BMP, or IL-6."
MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling.
Smad4 is required to induce digit ray primordia and to initiate the aggregation and differentiation of chondrogenic progenitors in mouse limb buds.
-
Mouse Smad4 deletion disrupts digit-ray condensation and chondrogenic progenitor differentiation.
"Smad4 deficiency blocked the aggregation of Sox9-positive progenitors, thereby preventing chondrogenic differentiation as revealed by absence of collagen type II."
TGFbeta superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population.
-
Smad4 loss disrupts organization of nephrogenic mesenchyme around ureteric tips.
"removal of Smad4 in nephrogenic mesenchyme using the Bmp7(cre/+) allele leads to disorganization of the nephrogenic mesenchyme and impairment of mesenchyme induction."
SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes.
-
SMAD4 antisense reduces nitric-oxide-donor-induced apoptosis in ventricular cardiomyocytes.
"inhibition of SMAD4 synthesis using SMAD4 antisense oligonucleotides reduced the number of apoptotic cells under stimulation with SNAP from 13.3 +/- 1.2% to control levels (8 +/- 1%, p < 0.05, n = 6)."
TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development.
-
SMAD2/4-LEF1 complexes promote transcription and epithelial remodeling during mouse palate development.
"Our paper is the first to show that the Smad2,4/LEF1 complex replaces beta-catenin/LEF1 during activation of EMT in vivo by TGFbeta3."
BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
-
SMAD4 depletion impairs stimulus-dependent hypertrophic responses in neonatal rat cardiomyocytes.
"silencing of Smad 1 or 4 using small interfering RNA diminished the ability of phenylephrine to induce hypertrophy in NRCs."
Activin signal transduction in the fetal rat adrenal gland and in human H295R cells.
-
Activin signaling components are expressed and functional in adrenal models; this does not establish adrenal organogenesis by SMAD4.
"the elements of the activin signaling pathway are present, intact, and functional."
Insulin-like growth factor-binding protein-5-induced laminin gamma1 transcription requires filamin A.
-
A cleaved filamin-A fragment recruits SMAD3/4 during laminin-gamma1 transcriptional regulation.
"Following cleavage, there is enhanced recruitment of Smad3/4 to a C-terminal FLNa fragment with nuclear translocation and subsequent binding to the promoter region of the laminin gamma1 (lamc1) gene."
Characterization of human FAST-1, a TGF beta and activin signal transducer.
-
Human FAST1 binds SMAD2 and activates a ligand-responsive reporter that requires endogenous SMAD4.
"hFAST-1 shared with xFAST-1 the ability to bind to human Smad2 and activate an activin response element (ARE)."
-
Human FAST1 binds SMAD2 and activates a ligand-responsive reporter that requires endogenous SMAD4.
"The hFAST-1-dependent activation of ARE was completely dependent on endogenous Smad4 and stimulation by a TGF beta-like ligand."
Smad3 prevents beta-catenin degradation and facilitates beta-catenin nuclear translocation in chondrocytes.
-
SMAD3 and SMAD4 cooperate to protect beta-catenin from degradation in chondrocytes.
"Both Smad3 and Smad4 were required for the interaction with beta-catenin and protected beta-catenin from an ubiquitin-proteasome-dependent degradation."
cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.
-
cAMP reduces CBP1 association with SMAD2/3/4 transcriptional complexes in cardiac fibroblasts.
"reduced binding of the transcriptional coactivator CREB-binding protein 1 to transcriptional complexes containing Smad2, Smad3, and Smad4."
Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.
Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells.
-
SMAD4 supports delayed TGF-beta-dependent MAP kinase activation in pancreatic acinar cells.
"adenoviral-mediated expression of dominant negative Smad4 blocked the ability of TGF-beta to activate acinar cell MAP kinase, demonstrating that this activation is downstream of Smads."
[High glucose induces sumoylation of Smad4 via SUMO2/3 in glomerular mesangial cells].
-
High glucose increases SMAD4 SUMO2/3 modification in mesangial cells.
"the sumolyation (SUMO2/3) of Smad4 was enhanced significantly in the high glucose groups compared with the control group (P < 0.05)."
Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium.
UniProt Q13485 curated record
-
Curated experimental localization places SMAD4 in a cytoplasmic pool that translocates to the nucleus during signaling.
"Cytoplasmic in the absence of ligand. Migrates to the nucleus when complexed with R-SMAD"
Myocardial deletion of Smad4 using a novel α skeletal muscle actin Cre recombinase transgenic mouse causes misalignment of the cardiac outflow tract.
-
Early myocardial Smad4 deletion causes ventricular septal defects, impaired trabeculation and compact-myocardial thinning.
"myocardial Smad4 conditional knockout fetuses exhibited cardiac defects, including double-outlet right ventricle (DORV) (Fig. 4D,H), ventricular septal defect (VSD) (Fig. 4D,H), decreased density of trabeculae in the ventricles and thinning of the compact layer of the ventricular myocardium (Fig. 4B,D,H,F)."